Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Profit After Tax (2009 - 2026)

Charles River Laboratories International (CRL) posted Profit After Tax of -$1.5 million for Q2 2026, up 90.02% on a QoQ basis from -$14.8 million in Q1 2026, and down 102.81% year-over-year from $52.7 million in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Profit After Tax (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Profit After Tax for 18 years, with the latest figure at -$1.5 million in Q2 2026.

  • On a quarterly basis, Profit After Tax fell 102.81% year-over-year to -$1.5 million in Q2 2026; TTM through Jun 2026 was -$239.2 million, a 268.73% decrease from a year earlier, with the FY2025 full-year figure at -$144.3 million, down 670.71% from the prior year.
  • Profit After Tax was -$1.5 million for Q2 2026 at Charles River Laboratories International, up from -$14.8 million in the prior quarter.
  • The five-year high for Profit After Tax was $189.1 million in Q4 2022, with the low at -$278.5 million in Q4 2025.
  • Average Profit After Tax over 5 years is $46.5 million, with a median of $81.3 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Profit After Tax soared 48.94% in 2022, then tumbled 213.12% in 2024.
  • Over 5 years, Profit After Tax stood at $189.1 million in 2022, then slipped by 0.08% to $189.0 million in 2023, then sank by 213.12% to -$213.7 million in 2024, then tumbled by 30.28% to -$278.5 million in 2025, then soared by 99.47% to -$1.5 million in 2026.
  • The last three Profit After Tax figures came in at -$1.5 million (Q2 2026), -$14.8 million (Q1 2026), and -$278.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 258.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 121.36 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 72.58 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -1.48 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -13.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -57.32 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -426,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -4.36 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -1.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 -1.48 Mn
Mar 28, 2026 -14.84 Mn
Dec 27, 2025 -278.47 Mn
Sep 27, 2025 55.56 Mn
Jun 28, 2025 52.69 Mn
Mar 29, 2025 25.88 Mn
Dec 28, 2024 -213.75 Mn
Sep 28, 2024 70.30 Mn
Jun 29, 2024 94.26 Mn
Mar 30, 2024 74.48 Mn
Dec 30, 2023 188.95 Mn
Sep 30, 2023 88.02 Mn
Jul 1, 2023 99.44 Mn
Apr 1, 2023 103.95 Mn
Dec 31, 2022 189.11 Mn
Sep 24, 2022 97.61 Mn
Jun 25, 2022 110.66 Mn
Mar 26, 2022 95.23 Mn
Dec 25, 2021 139.83 Mn
Sep 25, 2021 105.16 Mn